Acorda Therapeutics | Le Bénéfice D'Exploitation



Operating Profit Changement Date
Acadia Pharmaceuticals USD 153.5M 121.86M 2024-12
Agios Pharmaceuticals USD -125037000 1.11B 2024-12
ALKERMES USD 162.69M 57.93M 2024-12
Amgen USD 2.31B 182M 2024-12
Arrowhead Research USD -161412000 791K 2024-12
Biogen USD 441.4M 24.4M 2024-12
BioMarin Pharmaceutical USD 161.41M 47.51M 2024-12
Cipla INR 17.09B 952.7M 2024-12
Clal Biotechnology ILS -1738000 7.46M 2022-12
Compugen USD -7483000 11.98M 2024-12
CSL USD 1.2B 1.41B 2024-06
Cytokinetics USD -139040000 1.76M 2024-12
Gilead Sciences USD 2.24B 215M 2025-03
GlaxoSmithKline GBP 696M 507M 2024-12
Grifols EUR 371.86M 54.83M 2024-12
Halozyme Therapeutics USD 175.5M 12.3M 2024-12
Insmed USD -230414000 16.98M 2024-12
Ligand Pharmaceuticals USD -9637000 5.07B 2024-12
MannKind USD 13.1M 4.92M 2024-12
Merck EUR 1.2B 100M 2024-12
Moderna USD -1246000000 1.18B 2024-12
Neurocrine Biosciences USD 142M 41.8M 2024-12
Novartis USD 2.28B 1.34B 2024-12
Pfizer USD -409000000 5.57B 2024-12
Sanofi EUR 2.28B 1.42B 2025-03
Teva Pharmaceutical Industries USD 455M 506M 2024-12
Ultragenyx Pharmaceutical USD -122278000 9.71M 2024-12
Vertex Pharmaceuticals USD 1.03B 90.3M 2024-12



Acorda Therapeutics Le Bénéfice D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.